版權說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權,請進行舉報或認領
文檔簡介
1、第1頁/共42頁第2頁/共42頁第3頁/共42頁第4頁/共42頁GENETIC FACTORCONGENITAL ACQUIREDLONG QT SYNDROMELONG QT SYNDROME( FORME FRUSTE ) - IT SHOULD BE REMEMBERED THE LOW PENETRANCE OF GENETIC DISORDERS - BETWEEN ENVIRONMENTAL FACTORS THE MOST IMPORTANT SEEMS TO BE THE CONCOMITANT HYPOKALEMIAFIGURE 1 - SCHEMATIC REPRESENT
2、ATION OF DIFFERENT FACTORS BEING INVOLVED IN TDP INDUCTIONTRIGGER (DRUGS)ENVIRONMENTAL FACTORS第5頁/共42頁Genetic characterization of congenital LQT syndrome第6頁/共42頁Mechanims of Drug-induced QT Prolongation and TdP 1lThe blockade of Ikr current by antiarrhythmic drugs that are capable of prolonging the
3、action potential duration is at least in part responsible for their proarrhythmic effect. lIt is interesting to note that many other drugs that cause the development of early afterdepolarizations and TdP block the Ikr channel. lThe incidence of TdP remain low, however, and not all drugs that block I
4、kr have the same arrhythmogenic potential. The precise reason for the different effects of Ikr blocker is unknown.第7頁/共42頁Mechanims of Drug-induced QT Prolongation and TdP 2lThus, in an ordinary situation, the administration of an Ikr blocker might not prolong the QT interval.lHowever in the presenc
5、e of an otherwise subclinical lesion in the repolarization mechanisms (i.e. reduced repolarization reserve), the same Ikr blocker may precipitate marked QT prolongation and TdP.第8頁/共42頁Mechanims of Drug-induced QT Prolongation and TdP 3lThe causes for these lesions may be acquired (e.g. myocardial i
6、nfarction, congestive heart failre, ischemia, etc.) or congenital (formes frustes of congenital long QT syndrome).lThe extent of QT prolongation and risk of TdP associated with a given drug may not be linearly related to the dose of plasma level of the drug, because patient and metabolic factors are
7、 also important (e.g. gender, electrolyte levels, etc)lThere is not a simple relationship of drug-induced QT prolongation and the likelihood of the development of TdP which can sometimes occur without any noticeable prolongation of the QT interval.第9頁/共42頁Torsades de Pointes第10頁/共42頁Factors Modulate
8、 the Effects of Drugs That Block IKr Hypokalemia and hypomagnesemia Hypertrophy and heart failure Gender Metabolic factors Sympathetic activity Multiple actions of drugs that block IKr “Forme fruste” of the congenital long QT syndrome 第11頁/共42頁Part 1: Cardiac Drugs able to induce QT Prolongation and
9、 TdP第12頁/共42頁Class Antiarrhythmics Quinidinel Blocks the delayed rectifier Ikr as well as IKsl Quinidine Syncopel Causes QT prolongation early during therapy , usually within 1 weekl QT prolongation 1.5%l TdP 1% 8.8%, especially when QT interval 520ms, hypokalemia and bradycardia 第13頁/共42頁第14頁/共42頁C
10、lass III Antiarrhythmic Drugs 1d, l Sotalol Blocks the delayed rectifier Ikr potassium current No effect on the slow component Iks current Additional -blocking effect Incidence of TdP increases with dose and the baseline values of the QT interval. TdP occurred early even with low doses of oral d,l-s
11、otalol, especially in patients with congestive heart failure and low ejection fraction. 第15頁/共42頁第16頁/共42頁Drug induced TDP: comparison between Quinidine and Sotalol第17頁/共42頁Class III Antiarrhythmic Drugs 2 AmiodaronelUnique drug which possesses pharmacological properties from all four antiarrhythmic
12、 classeslHas the same potent effects on QT prolongation as other Class III agents, but the associated incidence of TdP is very low.lTdP usually occurs during concomitant therapy with other QT prolonging drugs or in the context of severe electrolyte disturbance.lIntravenous amiodarone is also safe an
13、d effective for the treatment of ventricular tachyarrhythmias.第18頁/共42頁第19頁/共42頁 d- Sotalol Ibutilide Azimilide Tedisamil Ersentilide Dofetilide Dronedarone AlmokalantNew Class III drugs第20頁/共42頁第21頁/共42頁第22頁/共42頁第23頁/共42頁第24頁/共42頁第25頁/共42頁Part 2: Acquired Long QT Syndrome by Non- Antiarrhythmic Dru
14、gs第26頁/共42頁第27頁/共42頁Part 3 Drug Drug Interaction第28頁/共42頁Cytochrome P450(CYP) enzymes are divided into two classes on the basis of the fundamental characteristics of their substratesl Those primarily involved in the metabolism of drugs and other xenobioticsl Those involved in the biosynthesis and me
15、tabolism of steroid hormones and other endobiotics第29頁/共42頁第30頁/共42頁Part 4 How to Avoid Drug-Induced Torsades de Pointes第31頁/共42頁第32頁/共42頁第33頁/共42頁第34頁/共42頁第35頁/共42頁Flow chart for Sotalol administration 第36頁/共42頁Conclusions 1lThe discordance between QT prolongation and the incidence of TDP among ant
16、iarrhythmic drugs that prolong ventricular refractoriness has stimulated immense interest in separating the salutary terapeutic effects from the adverse proarrhythmic action of antiarrhytmic drugs.lRapidly expanding knowledge of ion channel kinetics and structure, will aid the development of new dru
17、gs with specific profiles of channel blocking properties which have an effective antiarrhythmic action with minimal proarrhythmic potential.第37頁/共42頁Conclusions 2lFor non antiarrhythmic drugs wich prolongs QT interval, dose, duration of treatment, route of administration and magnitude of liver and k
18、idney clearances will affect the intensity and duration of the exposure to the drug. lThe most suitable raccomandation for a prescribing physician for both antiarrhythmic and non cardiac drugs is to consult the drug information sheets, the reference books, national formularies, and other drug compendia, to avoid unwanted drug interactions and additive effects on Ikr channels.第38頁/共42頁Conclusions 3lThe overall incidence of TdP in patients who use drugs that block Ikr is low (3%), and not all drugs that block Ikr have the same arrhythmogenic pot
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 范文父母感恩演講稿范文錦集九篇
- 七夕節(jié)創(chuàng)意文案(8篇)
- 新學期計劃范文集錦七篇
- 班長競選演講稿匯編八篇資料
- 給幼兒表揚信三篇
- 2020年遼寧沈陽中考滿分作文《鐘南山是我的啟明星》
- 健身器材品牌傳播與公關策略考核試卷
- 氨綸纖維的抗靜電性能研究考核試卷
- 鐵路軌道交叉施工方法考核試卷
- 中秋放假前安全教育國旗下講話稿
- 高中物理 人教版 必修三《電路及其應用》單元設計
- 中學2024-2025年度學校工作計劃
- 延安高新區(qū)總體規(guī)劃方案
- 電商培訓合同
- 裝飾畫(綜合材料)
- 茯苓的種植和加工
- 大學生職業(yè)規(guī)劃大賽成長賽道參賽作品
- 平面控制測量-坐標正反算(工程測量)
- 幼兒園中層管理培訓
- 2024年教師職稱評審考試試題2及含答案1
- 相關方的需求和期望清單
評論
0/150
提交評論